The effects of palbociclib in combination with radiation in preclinical models of aggressive meningioma

Craig Horbinski(Northwestern University), John A. Kalapurakal(Northwestern University)
Neuro-Oncology Advances
January 1, 2021
10.1093/noajnl/vdab085
Cited by 22

Related Papers

Beyond thrombosis: the impact of tissue factor signaling in cancer
|Journal of Hematology & Oncology|2020|115
The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma
|Neuro-Oncology|2024|8
Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas
|Neuro-Oncology|2022|7